Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders
AssigneePharmaseq, Inc.
InventorWlodek Mandecki
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmaseq, Inc.
InventorWlodek Mandecki
Estimating the term…
A method is described for determining the sequence of nucleic acids. The method employs small solid phase particles having transponders, with a primary layer of an oligonucleotide of known sequence attached to the outer surface of the particle. A read/write scanner device is used to encode and decode data on the transponder. The stored data includes the sequence of the oligonucleotide immobilized on the transponder. The sequence of sample nucleic acids is determined by detecting annealing to an oligonucleotide bound to a particle, followed by decoding the transponder to determine the sequence of the oligonucleotide.
A method of determining the sequence of a target nucleic acid sequence in a sample, comprising the steps of:
A method of determining the sequence of target nucleic acid thought to contain a plurality of subsequences, comprising the steps of:
A kit for determining the sequence of target nucleic acids in a sample, comprising:
Dependencies are inferred from the claim text.